Upload
Featured Recent Articles Topics Login Upload

Search Results for 'sof patients'

sof patients published presentations and documents on DocSlides.

SOF/VEL/VOX
SOF/VEL/VOX
by pamella-moone
400/100/100 mg QD. N = 263. N = 152. W12. Placebo...
SOF/VEL 400/100 mg qd N = 75
SOF/VEL 400/100 mg qd N = 75
by danika-pritchard
W24. SOF/VEL. >. 18 years. Chronic HCV infect...
SOF + RBV
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
SOF/VEL/VOX
SOF/VEL/VOX
by celsa-spraggs
400/100/100 mg QD. N = 501. N = 440. W8. SOF/VEL ...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Safety and Efficacy of Daclatasvir
Safety and Efficacy of Daclatasvir
by tabitha
. Plus . Sofosbuvir. With or Without Ribavirin . ...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
The Paradox of Highly Effective
The Paradox of Highly Effective
by Kingslayer
Sofosbuvir. . Combo Therapy . Despite . Slow . He...
ION-4
ION-4
by briana-ranney
Design. LDV/SOF. Open-label. ION-4 . Study. : LDV...
Slides for today’s webinar are available on the CIHS website at:
Slides for today’s webinar are available on the CIHS website at:
by tatiana-dople
Slides for today’s webinar are available on the...
Treatment of Chronic HCV
Treatment of Chronic HCV
by lam
with Direct-Acting Antivirals (DAAs). www.hcvguide...
FISSION Design Objective
FISSION Design Objective
by travis
Non . inferiority. of SOF + RBV : SVR. 12. (. 2-...
Virological characterization of patients with CHC and failure to a
Virological characterization of patients with CHC and failure to a
by isabella2
glecaprevir. /. pibrentasvir. or . voxilaprevir. ...
Hepatitis C: A New Era In Treatment And Cure
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
Description of Antivirals for Hepatitis C
Description of Antivirals for Hepatitis C
by conchita-marotz
LCDR Dwayne David, . PharmD. , BCPS, NCPS. Cherok...
Out With the Old and In With the New, Again?
Out With the Old and In With the New, Again?
by test
Out With the Old, In With the New. Current Standa...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Opportunities & Challenges:
Opportunities & Challenges:
by pasty-toler
Expanding Access to Hepatitis C Treatment . Gregg...
CURRY
CURRY
by faustina-dinatale
Design. Open-label. CURRY . Study. : SOF + RBV fo...